Advertisement
Advertisement

LMAT

LMAT logo

LeMaitre Vascular, Inc.

90.74
USD
-1.88
-2.03%
Apr 30, 15:59 UTC -4
Closed
exchange

Pre-Market

94.13

+3.39
+3.74%

LeMaitre Vascular, Inc. Profile

About

LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time.

Info & Links

CEO

George W. LeMaitre

Headquarters

63 SECOND AVENUE
BURLINGTON, MA 01803, UNITED STATES

Industry

Medical Products

Sector

Medical

Website

www.lemaitre.com

Auditor

GRANT THORNTON LLP

Share holders

155

Employees

664

LeMaitre Vascular, Inc. Statistics

Valuation Measures

Market Capitalization2

2.11B

Enterprise Value

2.26B

Enterprise Value/EBITDA(ttm)

36.45

Price to Earnings Ratio(ttm)

55.15

Price to Sales(ttm)

10.65

Price to Book(mrq)

6.85

Price to Cash(ytd)

56.52

Profitability

Gross Margin(ttm)

68.63%

Operating Margin(ttm)

19.40%

Profit Margin(ttm)

20.01%

Return on Equity(ttm)

13.15%

Return on Invested Capital(ttm)

12.49%

Return on Assets(ttm)

11.47%

Income Statement

Revenue(ttm)

219.86M

Revenue Per Share(ttm)

9.75

Gross Profit(ttm)

150.90M

EBITDA(ttm)3

61.93M

Net Income Available to Common(ttm)

44.04M

Diluted EPS(ttm)

1.83

Share Statistics

Beta (5Y Monthly)

0.96

52-Week Change

40.03%

S&P 500 52-Week Change

10.97%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

22.56M

Dividend Yield

0.63%

Float4

20.06M

% Held by Insiders

10.79%

% Held by Institutions

84.64%

Balance Sheet

Total Cash(mrq)

299.72M

Total Cash Per Share(mrq)

13.29

Total Debt(mrq)

167.77M

Total Debt/Equity(mrq)

49.74%

Current Ratio(mrq)

13.14%

Quick Ratio(mrq)

5.52%

Book Value Per Share(mrq)

14.96

Cash Flow

Operating Cash Flow Per Share(ytd)

1.94

Free Cash Flow(ytd)

37.16M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement